AKT1 and colorectal cancer: Moreover, Xiao et al. (2022) showed that metformin downregulated INHBA, a key ligand of TGF-β signaling, in colorectal cancer cells, thereby inhibiting PI3K/Akt activation and cell proliferation [84].